AT473010T - Enzymes for pharmaceutical use - Google Patents

Enzymes for pharmaceutical use

Info

Publication number
AT473010T
AT473010T AT05744343T AT05744343T AT473010T AT 473010 T AT473010 T AT 473010T AT 05744343 T AT05744343 T AT 05744343T AT 05744343 T AT05744343 T AT 05744343T AT 473010 T AT473010 T AT 473010T
Authority
AT
Austria
Prior art keywords
enzymes
pharmaceutical use
pharmaceutical
use
Prior art date
Application number
AT05744343T
Other languages
German (de)
Inventor
Allan Svendsen
Svend Kaasgaard
Kim Borch
Morten Fischer
Dan Pettersson
Peter Gregory
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DKPA200400810 priority Critical
Priority to DKPA200500101 priority
Application filed by Novozymes As filed Critical Novozymes As
Priority to PCT/DK2005/000342 priority patent/WO2005115445A1/en
Publication of AT473010T publication Critical patent/AT473010T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
AT05744343T 2004-05-24 2005-05-24 Enzymes for pharmaceutical use AT473010T (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DKPA200400810 2004-05-24
DKPA200500101 2005-01-20
PCT/DK2005/000342 WO2005115445A1 (en) 2004-05-24 2005-05-24 Enzymes for pharmaceutical use

Publications (1)

Publication Number Publication Date
AT473010T true AT473010T (en) 2010-07-15

Family

ID=34968404

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05744343T AT473010T (en) 2004-05-24 2005-05-24 Enzymes for pharmaceutical use

Country Status (12)

Country Link
US (2) US20110158976A1 (en)
EP (1) EP1755656B1 (en)
JP (1) JP2008500055A (en)
AT (1) AT473010T (en)
AU (1) AU2005247061A1 (en)
BR (1) BRPI0510817A (en)
CA (1) CA2586222A1 (en)
DE (1) DE602005022187D1 (en)
DK (1) DK1755656T3 (en)
MX (1) MXPA06013239A (en)
RU (1) RU2389504C2 (en)
WO (1) WO2005115445A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
ES2358092T3 (en) 2003-10-10 2011-05-05 Novozymes A/S Protease variants.
BRPI0512341A (en) 2004-06-21 2008-03-04 Novozymes As isolated polypeptide having protease activity, sequence isolated nucleic acid, nucleic acid construct, expression vector, recombinant host cell, plant or transgenic plant part, non-transgenic human animal, using at least one protease, methods for producing a polypeptide, for improving the nutritional value of an animal feed, and to treat protein, animal feed, and animal feed additive
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
BRPI0819662A2 (en) * 2007-12-04 2015-06-16 Novozymes As Protease, the method for treating diseases, and use of a protease
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
CN102046782A (en) * 2008-06-03 2011-05-04 诺维信公司 Method for producing a casein hydrolysate
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
ES2668909T3 (en) * 2009-01-06 2018-05-23 Galenagen, Llc Compositions comprising protease, amylase and lipase for use in the treatment of Staphylococcus aureus infections
EP2373693A4 (en) 2009-01-06 2012-04-25 Curelon Llc Compositions and methods for the treatment or the prevention oral infections by e. coli
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2011000924A1 (en) 2009-07-03 2011-01-06 Abbott Products Gmbh Spray-dried amylase, pharmaceutical preparations comprising the same and use
US8784884B2 (en) * 2009-09-17 2014-07-22 Stephen Perrett Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
GB2503852B (en) 2011-04-21 2018-12-12 Curemark Llc Compounds for the treatment of neuropsychiatric disorders
CN103703139A (en) 2011-07-22 2014-04-02 诺维信北美公司 Processes for pretreating cellulosic material and improving hydrolysis thereof
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
EP2914611B1 (en) 2012-11-01 2018-08-29 Novozymes A/S Method for removal of dna
EP2910129A1 (en) * 2014-02-21 2015-08-26 Clariant Produkte (Deutschland) GmbH Composition for enzymatic sludge removal from oil
JP2018171044A (en) * 2017-03-31 2018-11-08 株式会社東洋新薬 The composition for oral administration

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK564086A (en) 1986-11-25 1988-06-17 Novo Industri As Enzymatic detergent additive
DK173590D0 (en) 1990-06-06 1990-07-19 Novo Nordisk As Recombinant therapeutic lipases
US5614224A (en) * 1995-04-20 1997-03-25 Womack; Rick W. Nutritional supplement for diabetics
WO1996038170A1 (en) * 1995-05-31 1996-12-05 Medzyme N.V. Composition to improve digestibility and utilisation of nutrients
FR2747045B1 (en) * 1996-04-05 1998-06-26 Hooreman Michel New drug optimizing the viscosity of mucus and improving the functioning of the intestine
CZ20013345A3 (en) * 1999-03-17 2002-01-16 Solvay Pharmaceuticals Gmbh Medicament for treating diabetes mellitus
AU777210C (en) 2000-02-08 2005-08-04 Dsm Ip Assets B.V. Use of acid-stable subtilisin proteases in animal feed
AR032392A1 (en) 2001-01-19 2003-11-05 Solvay Pharm Gmbh Enzyme mixture, a pharmaceutical preparation and utilization of that preparation.
AU2003250830A1 (en) * 2002-06-12 2003-12-31 Bayer Healthcare Ag Regulation of human subtilase-like serine protease
CN1809635A (en) 2003-06-19 2006-07-26 诺维信公司 Proteases
US7485447B2 (en) 2003-06-19 2009-02-03 Novozymes A/S Proteases and methods for producing them
WO2004111222A1 (en) 2003-06-19 2004-12-23 Novozymes A/S Proteases
ES2358092T3 (en) 2003-10-10 2011-05-05 Novozymes A/S Protease variants.

Also Published As

Publication number Publication date
US20110158976A1 (en) 2011-06-30
EP1755656B1 (en) 2010-07-07
CA2586222A1 (en) 2005-12-08
DE602005022187D1 (en) 2010-08-19
JP2008500055A (en) 2008-01-10
MXPA06013239A (en) 2007-02-28
EP1755656A1 (en) 2007-02-28
DK1755656T3 (en) 2010-10-04
RU2389504C2 (en) 2010-05-20
BRPI0510817A (en) 2007-11-20
US20120207741A1 (en) 2012-08-16
WO2005115445A1 (en) 2005-12-08
AU2005247061A1 (en) 2005-12-08
RU2006145899A (en) 2008-06-27

Similar Documents

Publication Publication Date Title
AT536418T (en) Lipidverkapselte interference-rna
AT543462T (en) Allo-implant
AT381540T (en) Oximesther-photoinitiators
DE602004014644D1 (en) Teantrieb
AT473021T (en) Nichtkräuselnde polyhydroxyalkanoatnähte
AT457708T (en) Stentreduziersystem
AT503442T (en) glenoid
DE602004031824D1 (en) toothbrush
DK2243449T3 (en) Ultrasonic handpiece
AT538176T (en) Polymilchsäureharzzusammensetzung
AT493097T (en) Composite ophthalmic micro-cannula
AT511814T (en) centering intravaskularfilter
AT529505T (en) subtilase variants
DE602005025802D1 (en) Radial head implant
AT526869T (en) Hydratationsmonitor
DK1876897T3 (en) Active Substance Combinations
AT545389T (en) Heart valve system
AT553218T (en) Differential enzymatic fragmetierung
AT463199T (en) sphygmomanometer
DE602005036752T8 (en) Artificial disc
AT511206T (en) Ladungsträgerteilchenstrahlsystem
AT526916T (en) Illuminated infusion and inzisionskanüle
DK1722636T3 (en) Lipolytic fungal enzymes
AT442115T (en) Unterkiefervorschiebeorthese
DE602005020025D1 (en) active suspension

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties